Abstract 8806: Comparative Efficacy of GLP-1 Receptor Agonists versus SGLT-2 Inhibitors for Limb Outcomes in Patients with Peripheral Artery Disease: A Multicenter Propensity Score-Matched Real-World Study
Background: Patients with peripheral artery disease (PAD) face high risks of limb loss, revascularization, and cardiovascular events. While both GLP-1 receptor agonists (GLP-1 RAs) and SGLT-2 inhibitors (SGLT-2is) improve cardiovascular outcomes in type 2 diabetes, their comparative effectiveness on limb-specific ou...